BioSpace News Archive

Bio NC

The Median Drug Development Cost is $985 Million, According to New Study

The research included 63 of 355 new therapeutic drugs and biologics approved by the U.S. FDA between 2009 and 2018. See what is the drug development cost.

March 4, 2020
·
3 min read
·
Mark Terry
Deals

Allergan and AbbVie Turn Eyes to the FTC for Approval of their $63 Billion Merger

On Tuesday, the European Commission gave the green light to the merger following the divestiture of an investigational autoimmune treatment.

March 4, 2020
·
2 min read
·
Alex Keown
Drug Development

Allergan and Editas Dose First Patient in Historic CRISPR Trial for Inherited Blindness

“This dosing is a truly historic event—for science, for medicine, and most importantly for people living with this eye disease,” said Cynthia Collins, president and chief executive officer of Editas.

March 4, 2020
·
3 min read
·
Mark Terry
Pharm Country

Canine Arthritis Treatment Market Set for Healthy Growth, Supported by Advances in Veterinary Regenerative Medicines

High prevalence of obesity induced arthritis among dogs, growing adoption rate of canines, increasing awareness of the pet-related ailments, higher disposable income, and ease in regulatory approvals for groundbreaking drugs have been boosting growth of the canine arthritis treatment market.

March 4, 2020
·
3 min read
Pharm Country

Demand Mass Notification Systems on Upswing, Players Set an Eye on APEJ Market

According to the recent business intelligence report by Future Market Insights, the global market for mass notification systems was valued at US$ 3.2 Bn in 2019, and is expected to grow at a noticeable CAGR during 2029-2029.

March 4, 2020
·
3 min read
Pharm Country

Global Stretch Marks Treatment Market to Grow Owing to Innovative Strategy Adopted by Key Players

Stretch marks are marks on the body due to excessive weight gain. Some of the common causes of stretch marks are weight gain, pregnancy, puberty.

March 4, 2020
·
4 min read
Business

Cost of AstraZeneca’s New HQ Rises to $1.3 Billion, Tripling Original Target

AstraZeneca says the overrun is because of the complexity of the construction, inflation and other factors.

March 4, 2020
·
3 min read
·
Mark Terry
Drug Development

BioSpace Global Roundup, March 5

Life sciences companies from across the globe provide updates on their businesses and pipelines.

March 4, 2020
·
8 min read
·
Alex Keown
Pharm Country

Rising Incidences of Hospital-obtained Infections to Aid Global Hospital Infection Therapeutics Market

Hospital-obtained infections are exceptionally pervasive antagonistic occasions in the social insurance industry.

March 4, 2020
·
4 min read
Pharm Country

Rising Prevalence of Orthopedic Ailments to Propel Bone Wax Market

Bone wax is a product that enhances wound healing by aiding in hemostasis, i.e. the process of causing bleeding to stop.

March 4, 2020
·
3 min read